Succinylcholine chloride dihydrate (CAS 6101-15-1)
QUICK LINKS
Succinylcholine chloride dihydrate is a neuromuscular blocking agent that functions by binding to the nicotinic acetylcholine receptor at the motor endplate of the neuromuscular junction. This binding results in depolarization and subsequent paralysis of the skeletal muscles, making it useful for inducing muscle relaxation during experimental procedures. Succinylcholine chloride dihydrate′s mechanism of action involves the activation of the receptor, leading to sustained depolarization and preventing the transmission of nerve impulses to the muscle. This ultimately leads to temporary paralysis, allowing for easier manipulation of muscles during experimental studies. Succinylcholine chloride dihydrate′s mechanism of action involves the inhibition of acetylcholinesterase, leading to prolonged activation of the receptor and sustained muscle paralysis. Succinylcholine Chloride Dihydrate′s function in experimental applications involves its ability to induce rapid and short-lasting muscle relaxation.
Succinylcholine chloride dihydrate (CAS 6101-15-1) References
- Traumatically conditioned responses acquired during respiratory paralysis. | SANDERSON, RE., et al. 1962. Nature. 196: 2135-6. PMID: 13976228
- Physiological and pathophysiological down-regulation of cough. | Widdicombe, J. and Singh, V. 2006. Respir Physiol Neurobiol. 150: 105-17. PMID: 15878697
- A unified view of the role of electrostatic interactions in modulating the gating of Cys loop receptors. | Xiu, X., et al. 2005. J Biol Chem. 280: 41655-66. PMID: 16216879
- Determination of suxamethonium in a pharmaceutical formulation by capillary electrophoresis with contactless conductivity detection (CE-C(4)D). | Nussbaumer, S., et al. 2009. J Pharm Biomed Anal. 49: 333-7. PMID: 19121913
- Stability of succinylcholine chloride injection. | Schmutz, CW. and Mühlebach, SF. 1991. Am J Hosp Pharm. 48: 501-6. PMID: 2028996
- Eysenck's incubation of fear hypothesis: an experimental test. | Richards, M. and Martin, I. 1990. Behav Res Ther. 28: 373-84. PMID: 2256895
- Impact of temperature exposure on stability of drugs in a real-world out-of-hospital setting. | De Winter, S., et al. 2013. Ann Emerg Med. 62: 380-387.e1. PMID: 23711878
- Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent. | Zhang, X., et al. 2019. Theranostics. 9: 3107-3121. PMID: 31244944
- Susceptibility of male white-tailed deer (Odocoileus virginianus) to Brucella ovis infection. | Barron, SJ., et al. 1985. Am J Vet Res. 46: 1762-4. PMID: 4037505
- Drug-induced attenuation of alcohol consumption. A review and evaluation of claimed, potential or current therapies. | Mottin, JL. 1973. Q J Stud Alcohol. 34: 444-72. PMID: 4270100
- An evaluation of aversion and LSD therapy in the treatment of alcoholism. | Costello, CG. 1969. Can Psychiatr Assoc J. 14: 31-42. PMID: 4888140
- Role of stimulus generalization in the treatment of alcoholism. | Cohen, DJ. and Phelan, JG. 1971. Psychol Rep. 29: 771-8. PMID: 5124156
- A behaviorally oriented treatment program for alcoholism. | McBrearty, JF., et al. 1968. Psychol Rep. 22: 287-98. PMID: 5641234
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Succinylcholine chloride dihydrate, 25 g | sc-212965 | 25 g | $81.00 |